EMERYVILLE, Calif. and SAN FRANCISCO, Oct. 04, 2016 -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, in collaboration with the Autodesk BioNano Research Group, today announced the immediate availability of powerful open source tools for genetic design that leverage Autodesk’s Genetic Constructor, an extensible, open source, cloud CAD tool, and Amyris’s open source Genotype Specification Language (“GSL”), to more rapidly drive biological design and complex DNA construction. Autodesk BioNano Research and Amyris will be showcasing this solution today at SynBioBeta SF 2016 in San Francisco.
Best of Both Worlds
Those working in the genetic design community traditionally use a collection of disparate industrial and academic software tools that can be inefficient, difficult to acquire, set up, learn, and use. Genetic Constructor with GSL inside provides a seamless environment combining the power of a written genetic programming language along with an intuitive graphical environment. In the same way that early compilers in the software industry dramatically increased productivity and standardized the field, we expect that enabling everyone to access industrial grade tooling will greatly advance the synthetic biology sector. Industry wide adoption of an efficient common tool set and genetic programming language will benefit everyone.
“Amyris is clearly a leader in high-throughput DNA manufacturing. We are thrilled to enable any biologist to use GSL to ‘code’ their biological designs and we hope Genetic Constructor plus GSL dramatically speeds up the pace of genetic design,” stated Eli Groban, Head of BioNano Research at Autodesk.
“We are extremely pleased that Autodesk BioNano Research has adopted GSL as the first integration of a language for genomic design,” said Joel Cherry, President of Research & Development at Amyris. “Amyris used its deep experience designing DNA to develop a common-sense language for describing genetic designs. Building on notation that is familiar to any geneticist, the GSL compiler translates a request quickly into the information needed to create the DNA."
Continued Cherry, “Much as standardized computer languages like C revolutionized the early computer industry, we hope to establish GSL as a common industry standard platform. Genetic Constructor is the perfect visual complement to GSL.”
Genetic Constructor Plus GSL – Free Powerful Open Source Tool Set for Genetic Design
Genetic Constructor started from a collaboration between the Autodesk BioNano Research group and the University of Edinburgh. Autodesk’s BioNano Research Group aims to place the full power of Autodesk software in the hands of scientists, thereby enabling the ability to design on the BioNano scale. This web based, fully extensible, design software, available under an open source license, now incorporates an extension featuring an integrated development environment that is easier for scientists to use in the real-world process of assembling and testing actual, physical DNA coupled with Amyris’s GSL.
Genotype Specification Language (GSL), is a programming language that facilitates the rapid design of large and complex DNA constructs used to engineer genomes. The GSL compiler implements a high-level language based on traditional genetic notation, as well as a set of low-level DNA manipulation primitives. The language allows facile incorporation of parts from a library of cloned DNA constructs and from the “natural” library of parts in fully sequenced and annotated genomes. GSL was designed to engage genetic engineers in their native language while providing a framework for higher level abstract tooling. GSL was developed and open sourced by Amyris.
About Amyris
Amyris is the integrated renewable products company that is enabling the world’s leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules, specialty ingredients and consumer products. The company is delivering its No Compromise® products in focused markets, including specialty and performance chemicals, fragrance ingredients, and cosmetic emollients. More information about the company is available at www.amyris.com.
About Autodesk
Autodesk makes software for people who make things. If you’ve ever driven a high-performance car, admired a towering skyscraper, used a smartphone, or watched a great film, chances are you’ve experienced what millions of Autodesk customers are doing with our software. Autodesk gives you the power to make anything. For more information visit autodesk.com or follow @autodesk.
Autodesk and the Autodesk logo are registered trademarks or trademarks of Autodesk, Inc., and/or its subsidiaries and/or affiliates in the USA and/or other countries.
Amyris, and the Amyris logo are registered trademarks of Amyris, Inc. All other trademarks are the property of their respective owners.
Contacts: Eli Groban Head of Research -- BioNano Autodesk, Inc. Contact: [email protected] Peter DeNardo Director, Investor Relations and Corporate Communications Amyris, Inc. +1 (510) 740-7481 [email protected] [email protected]


Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 



